Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Carlomagno

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Neuroimage. Reports|June 26, 2025
Whole-brain computation of cognitive versus acoustic errors in music: A mismatch negativity studyL Bonetti, F Carlomagno, M Kliuchko, et al.
Journal of Endocrinological Investigation|February 1, 1995
RET/PTC activation in human thyroid carcinomasA Fusco, M Santoro, M Grieco, et al.
Endocrinology|April 1, 1997
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potentialA M Cirafici, G Salvatore, G De Vita, et al.
Science (New York, N.Y.)|January 20, 1995
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2BM Santoro, F Carlomagno, A Romano, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1994
Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2AL Quadro, L Panariello, D Salvatore, et al.
The Journal of Clinical Investigation|May 1, 1992
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtypeM Santoro, F Carlomagno, I D Hay, et al.
Cancer Research|August 5, 2000
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survivalG De Vita, R M Melillo, F Carlomagno, et al.
Endocrinology|July 29, 1998
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's diseaseF Carlomagno, R M Melillo, R Visconti, et al.
Cancer Research|March 10, 1999
Ret-mediated mitogenesis requires Src kinase activityR M Melillo, M V Barone, G Lupoli, et al.
The EMBO Journal|June 3, 1996
Molecular heterogeneity of RET loss of function in Hirschsprung's diseaseF Carlomagno, G De Vita, M T Berlingieri, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Neuroimage. Reports|June 26, 2025
Whole-brain computation of cognitive versus acoustic errors in music: A mismatch negativity studyL Bonetti, F Carlomagno, M Kliuchko, et al.
Journal of Endocrinological Investigation|February 1, 1995
RET/PTC activation in human thyroid carcinomasA Fusco, M Santoro, M Grieco, et al.
Endocrinology|April 1, 1997
Only the substitution of methionine 918 with a threonine and not with other residues activates RET transforming potentialA M Cirafici, G Salvatore, G De Vita, et al.
Science (New York, N.Y.)|January 20, 1995
Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2BM Santoro, F Carlomagno, A Romano, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1994
Frequent RET protooncogene mutations in multiple endocrine neoplasia type 2AL Quadro, L Panariello, D Salvatore, et al.
The Journal of Clinical Investigation|May 1, 1992
Ret oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtypeM Santoro, F Carlomagno, I D Hay, et al.
Cancer Research|August 5, 2000
Tyrosine 1062 of RET-MEN2A mediates activation of Akt (protein kinase B) and mitogen-activated protein kinase pathways leading to PC12 cell survivalG De Vita, R M Melillo, F Carlomagno, et al.
Endocrinology|July 29, 1998
Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's diseaseF Carlomagno, R M Melillo, R Visconti, et al.
Cancer Research|March 10, 1999
Ret-mediated mitogenesis requires Src kinase activityR M Melillo, M V Barone, G Lupoli, et al.
The EMBO Journal|June 3, 1996
Molecular heterogeneity of RET loss of function in Hirschsprung's diseaseF Carlomagno, G De Vita, M T Berlingieri, et al.
Pageof 5